Global Atrial Fibrillation Market
Atrial Fibrillation Market Size And Forecast
According to Verified Market Research, Global Atrial Fibrillation Market was valued at USD 12.2 Billion in 2018 and is projected to reach USD 30.7 Billion by 2026, growing at a CAGR of 12.3% from 2019 to 2026.
Global Atrial Fibrillation Market Outlook
The growth of global atrial fibrillation market is majorly stimulated by the rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population. The technological advancements in microwave catheter ablation and radiofrequency along with rising occurrence of diseases caused by lifestyle habits such as drinking and smoking are further expected to boost the market growth. Furthermore, increasing demand for minimally invasive procedures and small recovery time post-surgery, and surging demand for smaller cardiac incisions are some other factors also expected to bolster the market growth. An increase in therapeutic expenses and scarcity of proficient doctors are the factors that might lead to stagnate the market growth.
Global Atrial Fibrillation Market Competitive Landscape
The Global Atrial Fibrillation Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as AtriCure Inc., Boston Scientific Corporation, Boehringer Ingelheim GmbH, Biosense Webster Inc., St. Jude Medical Inc., Johnson & Johnson Ltd., CardioFocus Inc., Sanofi-Aventis, Endoscopic Technologies Inc., and Bristol-Myers Squibb Corporation.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.